Ambani Orgochem Board Meeting Outcome

Ambani Orgochem Convertible Warrants

Ambani Orgochem members approved a Rs 43.93 Crore preferential warrant issue and capital changes. Promoters receive 30.1 lakh of the 43.93 lakh warrants.

Value

₹43.93 Cr

Ambani Orgochem Investor Presentation: Key Takeaways

H1 FY27 consolidated: revenue ₹171.22 cr (+54.87%), EBITDA ₹11.32 cr (+43.00%), PAT ₹3.45 cr vs ₹0.19 cr. Strategy: capacity expansion and downstream specialty chemicals.

Ambani Orgochem Annual General Meeting

Ambani Orgochem's 1st EGM on 26 October 2026 took up four special resolutions. Items cover authorised capital, the capital clause, and preferential warrants.

Ambani Orgochem Convertible Warrants

Ambani Orgochem issued a corrigendum to its EGM notice, reducing the proposed preferential issue size of convertible warrants to Rs. 43.925 Crore following allotment revisions.

Value

₹43.92 Cr

Ambani Orgochem Convertible Warrants

Ambani Orgochem reduced its proposed preferential issue of convertible warrants by Rs. 0.25 Crore, following the removal of one allottee. The revised issue size is Rs. 43.925 Crore.

Value

₹43.92 Cr

Ambani Orgochem Other Announcement

The company submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 76.

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.